Challenges of international oncology trial collaboration-a call to action.

British Journal of Cancer
Monica TangJohn Zalcberg

Abstract

International collaboration in oncology trials has the potential to enhance clinical trial activity by expediting the recruitment of large patient populations, testing treatments in diverse populations and facilitating the study of rare tumours or specific molecular subtypes. However, a number of challenges continue to hinder the efficient and productive conduct of both commercial and non-commercial international clinical trials. These challenges include complex and burdensome regulatory requirements, the high cost of conducting trials, and logistical challenges associated with ethics review, drug supply and biospecimen collection and management. We propose solutions to promote oncology trial collaboration, such as regulatory reform, harmonisation of trial initiation and management processes and greater recognition and funding of academic (non-commercial) clinical trials. It is only through coordinated effort and leadership from researchers, regulators and those responsible for health systems that the full potential of international trial collaboration can be realised.

References

Nov 8, 2001·Bioethics·D D Reidpath, P A Allotey
Feb 12, 2004·Journal of Medical Ethics·A A HyderL Dawson
Jun 4, 2004·The New England Journal of Medicine·Thierry AndréUNKNOWN Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
Mar 4, 2006·BMJ : British Medical Journal·Akseli Hemminki, Pirkko-Liisa Kellokumpu-Lehtinen
Feb 20, 2008·Clinical Trials : Journal of the Society for Clinical Trials·Salim YusufRobert Temple
Mar 26, 2008·Archives of Internal Medicine·Sumit R MajumdarPaul W Armstrong
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 21, 2009·The New England Journal of Medicine·Seth W GlickmanKevin A Schulman
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward L TrimbleFrancoise Meunier
Sep 19, 2009·PloS One·Caroline J Savage, Andrew J Vickers
Nov 18, 2009·PLoS Medicine·Alex D McMahonGordon T McInnes
May 1, 2008·Journal of Oncology Practice·Linda R Bressler, Richard L Schilsky
Nov 4, 2011·Journal of the Neurological Sciences·Greg MinismanGary Cutter
Jun 22, 2012·PLoS Medicine·Trudie Lang, Sisira Siribaddana
Dec 20, 2012·PloS One·Catrin Tudur SmithJohn P Neoptolemos
Mar 12, 2013·European Heart Journal·Stuart PocockAngeles Alonso Garcia
Aug 2, 2013·Journal of the National Cancer Institute·Karyn Hede
Oct 1, 2013·Lancet·Kjetil SøreideUNKNOWN International Research Collaboration in Surgery (IRIS) ad-hoc working group
Dec 11, 2013·The Oncologist·Bostjan SerugaTanja Cufer
Oct 4, 2014·Clinical Trials : Journal of the Society for Clinical Trials·Andrew J Vickers
Feb 27, 2015·PloS One·Baris A OzdemirPeter J E Holt
Mar 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C DittrichUNKNOWN European Society for Medical Oncology (ESMO) Switzerland, and the European Organisation for Research and Treatment of Cancer
Oct 5, 2015·Seminars in Oncology·Manuel ValdiviesoCharles D Blanke
Mar 9, 2017·The Lancet Oncology·Lesley SeymourUNKNOWN RECIST working group
Dec 20, 2017·Annals of Internal Medicine·Nataliya Milman
Jan 14, 2018·Contemporary Clinical Trials·Grant D HuangUNKNOWN CTTI Recruitment Project Team
Feb 18, 2018·Clinical Trials : Journal of the Society for Clinical Trials·P TenaertsM Landray
Mar 29, 2018·The New England Journal of Medicine·Axel GrotheyTimothy Iveson
Oct 3, 2018·The Cancer Journal·Rebecca G BakerFrancis S Collins
Nov 16, 2018·The Medical Journal of Australia·John R Zalcberg, Michael Friedlander
Feb 9, 2019·Irish Journal of Medical Science·Niamh ClarkeNoel G McElvaney

❮ Previous
Next ❯

Citations

Apr 30, 2020·American Society of Clinical Oncology Educational Book·Ravindran KanesvaranHarpreet Singh
Nov 25, 2020·Cancers·Everardo Delforge Saad, Marc Buyse
Sep 23, 2020·Therapeutic Innovation & Regulatory Science·Jennifer LaiKit N Simpson
Jan 28, 2021·Annual Review of Medicine·Jennifer A FreedmanSteven R Patierno

❮ Previous
Next ❯

Software Mentioned

TOPGEAR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.